# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-20-176314
Filing Date
2020-06-23
Accepted
2020-06-23 13:26:30
Documents
41
Period of Report
2020-06-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d920890d8k.htm | 8-K | 31070
2 | EX-99.1 | d920890dex991.htm | EX-99.1 | 45676
3 | GRAPHIC | g920890ex99_1s10g1.jpg | GRAPHIC | 302376
4 | GRAPHIC | g920890ex99_1s11g1.jpg | GRAPHIC | 336571
5 | GRAPHIC | g920890ex99_1s12g1.jpg | GRAPHIC | 349344
6 | GRAPHIC | g920890ex99_1s13g1.jpg | GRAPHIC | 380691
7 | GRAPHIC | g920890ex99_1s14g1.jpg | GRAPHIC | 364995
8 | GRAPHIC | g920890ex99_1s15g1.jpg | GRAPHIC | 312636
9 | GRAPHIC | g920890ex99_1s16g1.jpg | GRAPHIC | 340755
10 | GRAPHIC | g920890ex99_1s17g1.jpg | GRAPHIC | 274913
11 | GRAPHIC | g920890ex99_1s18g1.jpg | GRAPHIC | 301564
12 | GRAPHIC | g920890ex99_1s19g1.jpg | GRAPHIC | 203272
13 | GRAPHIC | g920890ex99_1s1g1.jpg | GRAPHIC | 400331
14 | GRAPHIC | g920890ex99_1s20g1.jpg | GRAPHIC | 304568
15 | GRAPHIC | g920890ex99_1s21g1.jpg | GRAPHIC | 380349
16 | GRAPHIC | g920890ex99_1s22g1.jpg | GRAPHIC | 427567
17 | GRAPHIC | g920890ex99_1s23g1.jpg | GRAPHIC | 323469
18 | GRAPHIC | g920890ex99_1s24g1.jpg | GRAPHIC | 247616
19 | GRAPHIC | g920890ex99_1s25g1.jpg | GRAPHIC | 306445
20 | GRAPHIC | g920890ex99_1s26g1.jpg | GRAPHIC | 341362
21 | GRAPHIC | g920890ex99_1s27g1.jpg | GRAPHIC | 437821
22 | GRAPHIC | g920890ex99_1s28g1.jpg | GRAPHIC | 371625
23 | GRAPHIC | g920890ex99_1s29g1.jpg | GRAPHIC | 390638
24 | GRAPHIC | g920890ex99_1s2g1.jpg | GRAPHIC | 916182
25 | GRAPHIC | g920890ex99_1s30g1.jpg | GRAPHIC | 233436
26 | GRAPHIC | g920890ex99_1s31g1.jpg | GRAPHIC | 358642
27 | GRAPHIC | g920890ex99_1s32g1.jpg | GRAPHIC | 203206
28 | GRAPHIC | g920890ex99_1s33g1.jpg | GRAPHIC | 294949
29 | GRAPHIC | g920890ex99_1s34g1.jpg | GRAPHIC | 381658
30 | GRAPHIC | g920890ex99_1s35g1.jpg | GRAPHIC | 408531
31 | GRAPHIC | g920890ex99_1s36g1.jpg | GRAPHIC | 307924
32 | GRAPHIC | g920890ex99_1s37g1.jpg | GRAPHIC | 316688
33 | GRAPHIC | g920890ex99_1s38g1.jpg | GRAPHIC | 320800
34 | GRAPHIC | g920890ex99_1s39g1.jpg | GRAPHIC | 388016
35 | GRAPHIC | g920890ex99_1s3g1.jpg | GRAPHIC | 748009
36 | GRAPHIC | g920890ex99_1s4g1.jpg | GRAPHIC | 437688
37 | GRAPHIC | g920890ex99_1s5g1.jpg | GRAPHIC | 302053
38 | GRAPHIC | g920890ex99_1s6g1.jpg | GRAPHIC | 303440
39 | GRAPHIC | g920890ex99_1s7g1.jpg | GRAPHIC | 335761
40 | GRAPHIC | g920890ex99_1s8g1.jpg | GRAPHIC | 219877
41 | GRAPHIC | g920890ex99_1s9g1.jpg | GRAPHIC | 241704
| Complete submission text file | 0001193125-20-176314.txt |  | 19113672

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 20981424
SIC: 2834 Pharmaceutical Preparations